Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Undefined

ABSTRACT: Whole genome sequencing of 19 Burkholderia mallei strains from Pakistan

PROVIDER: PRJEB52165 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
		Other
	ERR9616690_1.fastq.gz	Fastqsanger.gz
	ERR9616690_2.fastq.gz	Fastqsanger.gz
	ERR9616700_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 46

Similar Datasets

The expression of virulence and antimicrobial related proteins in different Burkholderia mallei and Burkholderia pseudomallei isolates

Project description:Burkholderia mallei and Burkholderia pseudomallei are both potential biological threats agents. Melioidosis caused by B. pseudomallei is endemic in Southeast Asia and Northern Australia, while glanders caused by B. mallei infections are rare. Here we studied the proteomes of different B. mallei and B. pseudomallei isolates to determine species specific characteristics. Analyzing the expressed proteomes of B. mallei and B. pseudomallei revealed differences between B. mallei and B. pseudomallei but also between isolates from the same species. Expression of multiple virulence factors and proteins of several PKS/NRPS clusters was demonstrated. Proteome analysis can be used not only to identify bacteria but also to characterize the expression of important factors that putatively contribute to pathogenesis of B. mallei and B. pseudomallei.

2022-12-15 | PXD028126 | Pride

Burkholderia mallei

Project description:Burkholderia mallei Genome sequencing

| PRJNA264186 | ENA

Burkholderia mallei strain:BAC 86/19

Project description:Burkholderia mallei strain:BAC 86/19 Genome sequencing and assembly

| PRJNA789772 | ENA

undefined

Project description:Whole genome sequencing of Clostridium strains

| PRJEB60257 | ENA

undefined

Project description:Whole-genome sequencing of bacterial type strains

| PRJEB59311 | ENA

Burkholderia mallei strain:2002734299

Project description:Burkholderia mallei 2002734299 Genome sequencing

| PRJNA238811 | ENA

Burkholderia mallei strain:China7

Project description:Burkholderia mallei China7 Genome sequencing

| PRJNA238812 | ENA

Burkholderia mallei

Project description:Burkholderia mallei panel sequencing

| PRJNA214255 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Burkholderia mallei

Project description:Burkholderia mallei Genome sequencing (JHU/FMH)

| PRJNA266802 | ENA